Esther Paran

Esther Paran

Auto-generated profile, based on publicly available information

Esther Paran

Hypertension Unit, Soroka University Medical Center, Beer-Sheva, Israel

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2008 in Cardiovascular Drugs and Therapy
Verified
Journal Article
Closed access
PDF file
EPEsther Paran
Esther Paran
VNVictor Novack
Victor Novack
YEYechiel Nir Engelhard
Yechiel Nir Engelhard
IHInbal Hazan-Halevy
Inbal Hazan-Halevy

1 March 2013 in Journal Of Hypertension
Verified
Journal Article
Closed access
AAAnna Armoza
Anna Armoza
YHYulia Haim
Yulia Haim
ABAsher Basiri
Asher Basiri
TWTalya Wolak
Talya Wolak
EPEsther Paran
Esther Paran
Objectives: In our previous research the antihypertensive properties of lycopene-containing tomato oleoresin have been revealed. The present study was aimed to assess if oleoresin interferes in the inflammatory signalling in endothelial cells, imitating reduction of inflammatory processes in the vessel wall and in this way to propose the mechanism for the reduction of blood pressure by oleoresin. Methods and results: A wide number of functional and inflammatory markers were investigated in two cultured endothelial cell models [EA.hy926 and human umbilical vein endothelial cell (HUVEC)], exposed to oleoresin and carotenoids lycopene and lutein. All the carotenoids significantly improved basic endothelial function as measured by increased nitric oxide and decreased endothelin (ET-1) release. They were effective in attenuation of inflammatory nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signalling: decrease of tumour necrosis factor-alpha (TNF-α)-induced leukocytes adhesion, expression of adhesion molecules inter-cellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1), and nuclear translocation of NF-κB components as well as some revert of inhibitor of kappa B (IκB) ubiquitination. In addition, the carotenoids were able to inhibit NF-κB activation in transfected endothelial cells. When combined with lutein, oleoresin exerted synergistic effect on preclusion of leukocytes adhesion. Conclusions: Prevention of over-expression of adhesion molecules through inhibition of NF-κB signalling may be one of the main mechanisms driving carotenoids to attenuate inflammatory leukocyte adhesion to endothelium. This is the first profound study on the mechanisms involved in the positive action of natural tomato products in endothelial cells.

26 April 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
TWTalya Wolak
Talya Wolak
Yoav SharoniYoav Sharoni
Yoav Sharoni
JLJoseph Levy
Joseph Levy
Karin HermoniKarin Hermoni
Karin Hermoni
DSDavid Stepensky
David Stepensky
EPEsther Paran
Esther Paran
Oxidative stress is implicated in the pathogenesis of essential hypertension, a risk factor for cardiovascular morbidity and mortality. Tomato carotenoids such as lycopene and the colorless carotenoids phytoene and phytofluene induce the antioxidant defense mechanism. This double-blind, randomized, placebo-controlled study aimed to find effective doses of Tomato Nutrient Complex (TNC) to maintain normal blood pressure in untreated hypertensive individuals. The effect of TNC treatment (5, 15 and 30 mg lycopene) was compared with 15 mg of synthetic lycopene and a placebo over eight weeks. Results indicate that only TNC treatment standardized for 15 or 30 mg of lycopene was associated with significant reductions in mean systolic blood pressure (SBP). Treatment with the lower dose standardized for 5 mg of lycopene or treatment with 15 mg of synthetic lycopene as a standalone had no significant effect. To test carotenoid bioavailability, volunteers were treated for four weeks with TNC providing 2, 5 or 15 mg lycopene. The increase in blood levels of lycopene, phytoene, and phytofluene was dose dependent. Results suggest that only carotenoid levels achieved by the TNC dose of 15 mg lycopene or higher correlate to a beneficial effect on SBP in hypertensive subjects while lower doses and lycopene alone do not.

1 July 2010 in American Journal of Therapeutics
Verified
Journal Article
Closed access
EPEsther Paran
Esther Paran
OAOfra Anson
Ofra Anson
DLDavid T Lowenthal
David T Lowenthal
Both antihypertensive treatment and statins were proved to reduce mortality and morbidity from cardiovascular disease in the elderly. Yet their effect on cognitive functions of the elderly is unclear. In this study, 518 elderly were interviewed at their home six years ago. BP was measured and antihypertensive drug treatment and cognitive functions were evaluated. 318 of the original sample were re-examined (81% of the survivors). We evaluated the selective survival in relation to changes in BP, the specific drug usage and cognitive functioning. Beta blocker treatment increased the odds of survival but also the odds of decline in MMSE and memory scores. ACE-I treatment was also associated with decline in memory. Subjects treated with CCB had improved MMSE scores, memory, and performed better on tasks requiring concentration. Statins treatment in this study did not show any affect on cognitive functions. Although most subjects were treated by more than one antihypertensive drug, less than half were normalized at baseline and only one quarter at follow-up. Despite the low normalization rate, antihypertensive treatment regimen had been hardly changed during the six years follow-up. The use of statins, however, increased dramatically: from 6% at baseline to almost half at follow-up. According to our findings CCB emerges as the best option for reducing BP in elderly patients. It appeared to improve cognitive functions without hampering survival.

19 February 2010 in The Journal of Clinical Hypertension
Verified
Journal Article
Closed access
PDF file
GPGalit Perez‐Avraham
Galit Perez‐Avraham
SKSergio L. Kobal
Sergio L. Kobal
OEOhad Etzion
Ohad Etzion
VNVictor Novack
Victor Novack
TWTalya Wolak
Talya Wolak
EPEsther Paran
Esther Paran